Literature DB >> 2450833

Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.

G Del Giudice1, Q Cheng, D Mazier, N Berbiguier, J A Cooper, H D Engers, C Chizzolini, A S Verdini, F Bonelli, A Pessi.   

Abstract

In the present work, the hypothesis that individuals naturally exposed to Plasmodium falciparum malaria infection in endemic areas produce antibodies directed against non-repetitive epitopes of the circumsporozoite protein was investigated. Using a synthetic peptide reproducing the non-repetitive group-conserved region I sequence, we have shown that specific anti-region I antibodies are detectable in sera from endemic countries. Of these sera, 87% also had antibodies against the immunodominant repetitive epitope (Asn-Ala-Asn-Pro, NANP) of P. falciparum. In order to study the immunogenicity of this non-repetitive epitope, a synthetic peptide consisting of both region I and three (NANP) repeats [RI-(NANP)3] was used to immunize inbred strains of mice. H-2b mice produced antibodies against both the repetitive and the non-repetitive epitope. These antibodies were specific for each epitope, recognized P. falciparum sporozoites in immunofluorescence, and inhibited sporozoite penetration into human liver cells in vitro. Non-H-2b mice were completely unresponsive. Lymph node cells from H-2b mice immunized with RI-(NANP)3 peptide proliferated in the presence of RI-(NANP)3 and of (NANP)4 peptide, but never in the presence of RI peptide alone. These findings demonstrate that in the configuration used (i) the non-repetitive epitope region I does not carry T-helper epitopes; (ii) the (NANP) repetitive epitope may act as a carrier for the immune response to region I in mice; and (iii) therefore, immune response to region I in man probably depends on the recognition of T-cell epitopes similar to those involved in the anti-NANP response: i.e. such a T epitope may be NANP itself in responding individuals or another, not yet recognized, sporozoite T-cell epitope.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450833      PMCID: PMC1454514     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  The circumsporozoite gene of the Plasmodium cynomolgi complex.

Authors:  M R Galinski; D E Arnot; A H Cochrane; J W Barnwell; R S Nussenzweig; V Enea
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

2.  Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.

Authors:  F Zavala; J P Tam; M R Hollingdale; A H Cochrane; I Quakyi; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

3.  Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi.

Authors:  U Vergara; R Gwadz; D Schlesinger; V Nussenzweig; A Ferreira
Journal:  Mol Biochem Parasitol       Date:  1985-03       Impact factor: 1.759

4.  Conserved group-specific epitopes of the circumsporozoite proteins revealed by antibodies to synthetic peptides.

Authors:  U Vergara; A Ruiz; A Ferreira; R S Nussenzweig; V Nussenzweig
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

Authors:  G Del Giudice; J A Cooper; J Merino; A S Verdini; A Pessi; A R Togna; H D Engers; G Corradin; P H Lambert
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

Authors:  M F Good; W L Maloy; M N Lunde; H Margalit; J L Cornette; G L Smith; B Moss; L H Miller; J A Berzofsky
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

7.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

8.  Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes.

Authors:  D J Eichinger; D E Arnot; J P Tam; V Nussenzweig; V Enea
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

9.  Research toward malaria vaccines.

Authors:  L H Miller; R J Howard; R Carter; M F Good; V Nussenzweig; R S Nussenzweig
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

10.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.

Authors:  G Del Giudice; P H Lambert; K Mendis; A Pessi; M Tanner
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Authors:  Thomas Jaenisch; Kirsten Heiss; Nico Fischer; Carolin Geiger; F Ralf Bischoff; Gerhard Moldenhauer; Leszek Rychlewski; Ali Sié; Boubacar Coulibaly; Peter H Seeberger; Lucjan S Wyrwicz; Frank Breitling; Felix F Loeffler
Journal:  Mol Cell Proteomics       Date:  2019-01-10       Impact factor: 5.911

3.  MHC (RT1) restriction of the antibody repertoire to infection with the nematode Nippostrongylus brasiliensis in the rat.

Authors:  M W Kennedy; A E McIntosh; A J Blair; D McLaughlin
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  Multiple antigen peptide vaccines against Plasmodium falciparum malaria.

Authors:  Babita Mahajan; Jay A Berzofsky; Robert A Boykins; Victoria Majam; Hong Zheng; Rana Chattopadhyay; Patricia de la Vega; J Kathleen Moch; J David Haynes; Igor M Belyakov; Hira L Nakhasi; Sanjai Kumar
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

5.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein.

Authors:  Y P Shi; V Udhayakumar; M P Alpers; M M Povoa; A J Oloo; T K Ruebush; A A Lal
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Evidence for epitope-specific thymus-independent response against a repeat sequence in a protein antigen.

Authors:  N Kumar; H Zheng
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

7.  Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.

Authors:  Aissatou Toure-Balde; Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Mouhamadou Ndiaye; Georgette Aribot; Adama Tall; Cheikh Sokhna; Christophe Rogier; Giampietro Corradin; Christian Roussilhon; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

8.  High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria.

Authors:  Vittoria Offeddu; Ally Olotu; Faith Osier; Kevin Marsh; Kai Matuschewski; Vandana Thathy
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.